Reference
Zacherl MJ, et al. First Clinical Results for PSMA-Targeted alpha-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients. Journal of Nuclear Medicine 62: 669-674, No. 5, 10 May 2021. Available from: URL: http://doi.org/10.2967/jnumed.120.251017
Rights and permissions
About this article
Cite this article
225-actinium-PSMA/docetaxel/lutetium-177-PSMA-imaging-and-therapy. Reactions Weekly 1882, 14 (2021). https://doi.org/10.1007/s40278-021-05481-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-05481-4